The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 390.00
Bid: 386.00
Ask: 396.00
Change: 9.00 (2.36%)
Spread: 10.00 (2.591%)
Open: 380.00
High: 390.00
Low: 380.00
Prev. Close: 381.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 May 2019 17:36

RNS Number : 7629Z
Zotefoams PLC
21 May 2019
 

Zotefoams plc (the 'Company')

Grant of share awards

The Company announces that on 20 May 2019 the Executive Directors were granted the following conditional awards over the Company's Ordinary Shares of 5p each under the terms of the Company's Long Term Incentive Plan 2017 ('LTIP'):

Name

Number of shares

D B Stirling

Chief Executive Officer

73,070

G C McGrath

 Chief Financial Officer

48,352

The LTIP awards will vest on the third anniversary of the grant date subject to achieving the performance criteria detailed in the Company's Annual Report 2018. A holding period of two years following the vesting date will apply, such that the awards will not normally be released until the fifth anniversary of the grant date.

Further, on 20 May 2019 the Executive Directors were granted the following restricted share awards over the Company's Ordinary Shares of 5p each under the Company's Deferred Bonus Share Plan ('DBSP'):

Name

Number of shares

D B Stirling

Chief Executive Officer

2,677

G C McGrath

Chief Financial Officer

2,497

The DBSP awards will be released on the third anniversary of the grant date subject to satisfaction of service conditions.

The Notification of Dealing Form for each Executive Director can be found below.

 

This notification is made in accordance with the Market Abuse Regulation.

 

Enquiries:

 

James Adams

Interim Company Secretary

Zotefoams plc

21 May 2019

 

Tel: 020 8664 1600

 

 

About Zotefoams plc:

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA, to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell® Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Stirling

2.

Reason for the notification

a)

Position/status: Chief Executive Officer

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of performance shares under the Long Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

73,070

d)

Aggregated information:

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

73,070

£0.00

e)

Date of the transaction: 20 May 2019

f)

Place of the transaction: Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

2,677

d)

Aggregated information:

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

2,677

£0.00

e)

Date of the transaction: 20 May 2019

f)

Place of the transaction: Outside a trading venue

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Gary McGrath

2.

Reason for the notification

a)

Position/status: Chief Financial Officer

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Zotefoams plc

b)

LEI: 213800B6P256B5XN8D32

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of performance shares under the Long Term Incentive Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

48,352

d)

Aggregated information:

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

48,352

£0.00

e)

Date of the transaction: 20 May 2019

f)

Place of the transaction: Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 5 pence each

Identification code: GB0009896605

b)

Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£0.00

2,497

d)

Aggregated information:

Aggregate Price

Aggregate Volume

Aggregate Total

£0.00

2,497

£0.00

e)

Date of the transaction: 20 May 2019

f)

Place of the transaction: Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAKSFADLNEFF
Date   Source Headline
23rd Aug 20164:35 pmRNSPrice Monitoring Extension
12th Aug 20167:00 amRNSDirector/PDMR Shareholding
9th Aug 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Aug 20168:51 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSInterim Results
29th Jul 20168:30 amRNSHolding(s) in Company
20th Jul 20168:48 amRNSHolding(s) in Company
12th Jul 20162:18 pmRNSDirector/PDMR Shareholding
8th Jul 20164:40 pmRNSSecond Price Monitoring Extn
8th Jul 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 201610:31 amRNSDirector/PDMR Shareholding
13th Jun 20168:24 amRNSHolding(s) in Company
1st Jun 20164:18 pmRNSDirector/PDMR Shareholding
27th May 20169:10 amRNSChange in director's details
18th May 20163:37 pmRNSResult of AGM
18th May 20167:00 amRNSAGM Trading Update
13th May 201611:43 amRNSDirector/PDMR Shareholding
3rd May 20169:21 amRNSHolding(s) in Company
22nd Apr 20161:58 pmRNSDirector/PDMR Shareholding
20th Apr 20169:54 amRNSDirector/PDMR Shareholding
18th Apr 201610:18 amRNSAnnual Report and Accounts and Notice of 2016 AGM
15th Apr 20167:00 amRNSBest Chemicals PLC at the UK Stock Market Awards
12th Apr 20161:53 pmRNSDirector/PDMR Shareholding
6th Apr 201612:07 pmRNSDirector/PDMR Shareholding
1st Apr 20169:10 amRNSBoard Committee Changes
23rd Mar 20165:09 pmRNSDirector/PDMR Shareholding
23rd Mar 201611:30 amRNSDirector/PDMR Shareholding
23rd Mar 20168:27 amRNSHolding(s) in Company
23rd Mar 20168:25 amRNSHolding(s) in Company
22nd Mar 20164:22 pmRNSHolding(s) in Company
21st Mar 20162:41 pmRNSHolding(s) in Company
15th Mar 20167:00 amRNSPreliminary Results
14th Mar 20168:32 amRNSDirector/PDMR Shareholding
19th Feb 20164:35 pmRNSPrice Monitoring Extension
17th Feb 201611:27 amRNSHolding(s) in Company
12th Feb 20169:01 amRNSDirector/PDMR Shareholding
11th Feb 20167:00 amRNSAnnounces the launch of T-FIT® insulation products
19th Jan 201610:43 amRNSHolding(s) in Company
18th Jan 20169:11 amRNSHolding(s) in Company
14th Jan 20167:00 amRNSTrading Statement
12th Jan 20161:16 pmRNSDirector/PDMR Shareholding
10th Dec 20155:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20153:30 pmRNSHolding(s) in Company
1st Dec 201511:54 amRNSHolding(s) in Company
30th Nov 20159:59 amRNSTotal Voting Rights
25th Nov 20151:28 pmRNSApplication for the listing of shares
24th Nov 20157:00 amRNSAppointment of Finance Director Designate
2nd Nov 20157:00 amRNSThird Quarter Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.